Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hyperbaric Oxygenation | 30 | 2016 | 163 | 4.760 |
Why?
|
Brain Ischemia | 38 | 2023 | 3265 | 3.400 |
Why?
|
Stroke | 57 | 2024 | 9981 | 2.540 |
Why?
|
Cerebral Infarction | 18 | 2024 | 1011 | 2.150 |
Why?
|
Ischemic Attack, Transient | 18 | 2024 | 935 | 2.050 |
Why?
|
Brain Infarction | 9 | 2023 | 299 | 1.990 |
Why?
|
Diabetic Foot | 10 | 2018 | 355 | 1.960 |
Why?
|
Vagus Nerve Stimulation | 5 | 2015 | 199 | 1.550 |
Why?
|
Vitamin A | 3 | 2022 | 615 | 1.530 |
Why?
|
Foot Ulcer | 4 | 2015 | 59 | 1.520 |
Why?
|
Leukoaraiosis | 4 | 2013 | 120 | 1.380 |
Why?
|
Diffusion Magnetic Resonance Imaging | 19 | 2019 | 2737 | 1.170 |
Why?
|
Infarction, Middle Cerebral Artery | 9 | 2012 | 475 | 0.930 |
Why?
|
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2023 | 31 | 0.900 |
Why?
|
Diterpenes | 2 | 2022 | 173 | 0.900 |
Why?
|
Long QT Syndrome | 1 | 2023 | 453 | 0.670 |
Why?
|
Oxidative Stress | 11 | 2016 | 3086 | 0.670 |
Why?
|
Glycogen Phosphorylase | 1 | 2017 | 16 | 0.630 |
Why?
|
Cerebral Arterial Diseases | 2 | 2017 | 82 | 0.620 |
Why?
|
Brain | 31 | 2020 | 26385 | 0.610 |
Why?
|
Oxygen | 6 | 2015 | 4189 | 0.600 |
Why?
|
Carbon Monoxide Poisoning | 3 | 2012 | 66 | 0.570 |
Why?
|
Atmospheric Pressure | 2 | 2014 | 47 | 0.520 |
Why?
|
Troponin T | 4 | 2023 | 754 | 0.510 |
Why?
|
Synostosis | 1 | 2014 | 43 | 0.490 |
Why?
|
Glutathione Peroxidase | 7 | 2012 | 255 | 0.480 |
Why?
|
Blood Preservation | 1 | 2015 | 177 | 0.480 |
Why?
|
Olfactory Perception | 1 | 2014 | 54 | 0.470 |
Why?
|
Ear, External | 1 | 2014 | 161 | 0.470 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 2015 | 161 | 0.460 |
Why?
|
Toes | 1 | 2014 | 206 | 0.460 |
Why?
|
Recurrence | 6 | 2021 | 8340 | 0.460 |
Why?
|
Pterygopalatine Fossa | 1 | 2012 | 9 | 0.450 |
Why?
|
Rats | 20 | 2022 | 24260 | 0.450 |
Why?
|
Male | 115 | 2024 | 350118 | 0.450 |
Why?
|
Sodium Hydroxide | 1 | 2012 | 44 | 0.440 |
Why?
|
Ganglia, Autonomic | 1 | 2012 | 43 | 0.440 |
Why?
|
Aged | 77 | 2024 | 163280 | 0.440 |
Why?
|
Cerebral Cortex | 7 | 2009 | 5708 | 0.440 |
Why?
|
Intracranial Hemorrhages | 5 | 2024 | 855 | 0.430 |
Why?
|
Cerebrovascular Circulation | 9 | 2020 | 2731 | 0.430 |
Why?
|
Aged, 80 and over | 42 | 2024 | 57776 | 0.430 |
Why?
|
Pets | 1 | 2012 | 29 | 0.430 |
Why?
|
Lipid Peroxidation | 6 | 2011 | 270 | 0.420 |
Why?
|
Hearing Loss, Sudden | 1 | 2012 | 43 | 0.420 |
Why?
|
Daptomycin | 1 | 2012 | 73 | 0.420 |
Why?
|
Erythrocytes | 3 | 2015 | 2455 | 0.420 |
Why?
|
Smell | 1 | 2014 | 244 | 0.410 |
Why?
|
Delayed Diagnosis | 1 | 2015 | 441 | 0.410 |
Why?
|
Negative-Pressure Wound Therapy | 1 | 2014 | 150 | 0.410 |
Why?
|
Debridement | 1 | 2014 | 492 | 0.410 |
Why?
|
Birds | 1 | 2012 | 163 | 0.410 |
Why?
|
Magnetic Resonance Imaging | 34 | 2024 | 35421 | 0.400 |
Why?
|
Soft Tissue Injuries | 1 | 2013 | 176 | 0.400 |
Why?
|
Cerebrum | 1 | 2012 | 137 | 0.400 |
Why?
|
Vitamins | 1 | 2020 | 1622 | 0.390 |
Why?
|
Burns, Chemical | 1 | 2012 | 159 | 0.390 |
Why?
|
Neuroprotective Agents | 4 | 2019 | 941 | 0.380 |
Why?
|
Middle Aged | 76 | 2024 | 213383 | 0.380 |
Why?
|
Superoxide Dismutase | 6 | 2012 | 597 | 0.370 |
Why?
|
Self Care | 1 | 2015 | 786 | 0.370 |
Why?
|
Diagnostic Self Evaluation | 1 | 2012 | 230 | 0.360 |
Why?
|
Pyridoxine | 1 | 2010 | 102 | 0.360 |
Why?
|
Puerperal Disorders | 1 | 2012 | 275 | 0.350 |
Why?
|
Digestive System Abnormalities | 1 | 2010 | 52 | 0.350 |
Why?
|
Viscera | 1 | 2010 | 139 | 0.350 |
Why?
|
Cerebral Hemorrhage | 8 | 2024 | 2647 | 0.350 |
Why?
|
Urethral Stricture | 1 | 2009 | 51 | 0.340 |
Why?
|
Female | 96 | 2024 | 380194 | 0.340 |
Why?
|
Syncope | 1 | 2012 | 429 | 0.340 |
Why?
|
Magnetic Resonance Angiography | 3 | 2011 | 1442 | 0.340 |
Why?
|
Humans | 136 | 2024 | 744343 | 0.330 |
Why?
|
Radial Nerve | 1 | 2008 | 43 | 0.330 |
Why?
|
Cerebrovascular Disorders | 4 | 1999 | 1504 | 0.330 |
Why?
|
Anti-Bacterial Agents | 6 | 2018 | 7181 | 0.330 |
Why?
|
Predictive Value of Tests | 16 | 2020 | 15076 | 0.320 |
Why?
|
Hippocampus | 2 | 2020 | 3675 | 0.310 |
Why?
|
Rats, Wistar | 7 | 2016 | 1901 | 0.300 |
Why?
|
Craniofacial Abnormalities | 1 | 2010 | 315 | 0.300 |
Why?
|
Vision Disorders | 2 | 2012 | 1058 | 0.290 |
Why?
|
Neutropenia | 1 | 2012 | 895 | 0.290 |
Why?
|
International Normalized Ratio | 1 | 2008 | 367 | 0.290 |
Why?
|
Sympathetic Nervous System | 2 | 2008 | 514 | 0.290 |
Why?
|
Synaptic Transmission | 1 | 2012 | 1178 | 0.280 |
Why?
|
Atherosclerosis | 2 | 2017 | 3445 | 0.280 |
Why?
|
Burns | 2 | 2014 | 1815 | 0.270 |
Why?
|
Radiation Injuries | 1 | 2013 | 1180 | 0.270 |
Why?
|
Wound Healing | 3 | 2016 | 2785 | 0.270 |
Why?
|
Humeral Fractures | 1 | 2008 | 272 | 0.270 |
Why?
|
Vasoactive Intestinal Peptide | 2 | 2018 | 179 | 0.260 |
Why?
|
Ticlopidine | 1 | 2011 | 899 | 0.260 |
Why?
|
Diagnosis, Computer-Assisted | 2 | 2007 | 719 | 0.260 |
Why?
|
Atrial Fibrillation | 6 | 2023 | 5034 | 0.260 |
Why?
|
Fibrinolytic Agents | 5 | 2023 | 2158 | 0.250 |
Why?
|
Solitary Nucleus | 2 | 2015 | 63 | 0.250 |
Why?
|
Turkey | 6 | 2016 | 237 | 0.250 |
Why?
|
Drug Resistance | 1 | 2011 | 1609 | 0.250 |
Why?
|
Fever | 1 | 2012 | 1616 | 0.250 |
Why?
|
Thiobarbituric Acid Reactive Substances | 4 | 2007 | 46 | 0.250 |
Why?
|
Thrombocytopenia | 1 | 2012 | 1179 | 0.240 |
Why?
|
Trachea | 2 | 2015 | 1076 | 0.240 |
Why?
|
Carotid Stenosis | 3 | 2021 | 854 | 0.240 |
Why?
|
Cyclosporine | 1 | 2007 | 786 | 0.240 |
Why?
|
Device Removal | 1 | 2009 | 656 | 0.240 |
Why?
|
Heart Rate | 4 | 2015 | 4091 | 0.240 |
Why?
|
Gram-Positive Bacteria | 2 | 2016 | 184 | 0.230 |
Why?
|
Functional Laterality | 4 | 2012 | 2290 | 0.230 |
Why?
|
Risk Factors | 27 | 2024 | 72290 | 0.230 |
Why?
|
Severity of Illness Index | 11 | 2017 | 15540 | 0.230 |
Why?
|
Hyaluronoglucosaminidase | 1 | 2023 | 133 | 0.220 |
Why?
|
Gram-Negative Bacteria | 2 | 2016 | 270 | 0.220 |
Why?
|
Angioplasty | 1 | 2005 | 364 | 0.220 |
Why?
|
Piperacillin | 2 | 2012 | 41 | 0.220 |
Why?
|
Osteoporosis | 1 | 2012 | 1580 | 0.220 |
Why?
|
Penicillanic Acid | 2 | 2012 | 45 | 0.210 |
Why?
|
Osteomyelitis | 3 | 2018 | 402 | 0.210 |
Why?
|
Hyperhomocysteinemia | 1 | 2003 | 124 | 0.210 |
Why?
|
Proto-Oncogene Proteins c-fos | 2 | 2015 | 575 | 0.210 |
Why?
|
Vasculitis, Central Nervous System | 1 | 2002 | 42 | 0.210 |
Why?
|
Barotrauma | 3 | 2008 | 37 | 0.210 |
Why?
|
Thrombolytic Therapy | 4 | 2015 | 2161 | 0.210 |
Why?
|
Adult | 48 | 2023 | 214055 | 0.210 |
Why?
|
Infarction, Anterior Cerebral Artery | 1 | 2002 | 12 | 0.210 |
Why?
|
Anatomy | 1 | 2003 | 112 | 0.210 |
Why?
|
Diabetes Mellitus, Type 2 | 5 | 2014 | 11725 | 0.200 |
Why?
|
Tracheal Stenosis | 1 | 2003 | 226 | 0.200 |
Why?
|
Cardiomyopathies | 2 | 2020 | 1912 | 0.200 |
Why?
|
Treatment Outcome | 21 | 2023 | 63114 | 0.200 |
Why?
|
Neurons | 2 | 2020 | 9338 | 0.190 |
Why?
|
Cerebral Arteries | 3 | 2008 | 494 | 0.190 |
Why?
|
Aging | 3 | 2011 | 8664 | 0.190 |
Why?
|
Carotid Arteries | 1 | 2005 | 952 | 0.190 |
Why?
|
Motor Activity | 3 | 2014 | 2714 | 0.190 |
Why?
|
Myocardium | 2 | 2006 | 4776 | 0.190 |
Why?
|
Risk Assessment | 13 | 2021 | 23338 | 0.190 |
Why?
|
Disease Progression | 9 | 2011 | 13284 | 0.190 |
Why?
|
Endarterectomy, Carotid | 1 | 2005 | 546 | 0.190 |
Why?
|
Hand | 2 | 2012 | 884 | 0.180 |
Why?
|
Ki-67 Antigen | 1 | 2022 | 644 | 0.180 |
Why?
|
Warfarin | 1 | 2008 | 1496 | 0.180 |
Why?
|
Animals | 25 | 2022 | 168757 | 0.180 |
Why?
|
Reproducibility of Results | 10 | 2017 | 19905 | 0.180 |
Why?
|
Creatine Kinase | 1 | 2002 | 694 | 0.180 |
Why?
|
Cartilage | 1 | 2003 | 818 | 0.180 |
Why?
|
Retrospective Studies | 24 | 2021 | 77449 | 0.170 |
Why?
|
Tomography, X-Ray Computed | 11 | 2019 | 20129 | 0.170 |
Why?
|
Kidney Diseases | 2 | 2009 | 2149 | 0.170 |
Why?
|
Causality | 3 | 2011 | 1275 | 0.170 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2015 | 3068 | 0.170 |
Why?
|
Blood Pressure | 6 | 2015 | 8554 | 0.170 |
Why?
|
Rats, Sprague-Dawley | 9 | 2012 | 8301 | 0.170 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2021 | 339 | 0.170 |
Why?
|
Aspirin | 1 | 2011 | 3282 | 0.160 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2023 | 652 | 0.160 |
Why?
|
Cerebral Angiography | 4 | 2010 | 1285 | 0.160 |
Why?
|
Atrial Function, Left | 1 | 2020 | 173 | 0.160 |
Why?
|
In Situ Nick-End Labeling | 1 | 2020 | 643 | 0.160 |
Why?
|
Risk | 5 | 2021 | 9687 | 0.160 |
Why?
|
Heart Septal Defects, Atrial | 2 | 1998 | 478 | 0.160 |
Why?
|
Regression Analysis | 3 | 2017 | 6459 | 0.160 |
Why?
|
Prognosis | 11 | 2020 | 29063 | 0.160 |
Why?
|
Hemiplegia | 1 | 1998 | 135 | 0.160 |
Why?
|
Phenotype | 6 | 2014 | 16365 | 0.160 |
Why?
|
Statistics, Nonparametric | 4 | 2017 | 2886 | 0.150 |
Why?
|
Heart Atria | 2 | 2020 | 1357 | 0.150 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2024 | 3255 | 0.150 |
Why?
|
Observer Variation | 4 | 2008 | 2593 | 0.150 |
Why?
|
Acute Coronary Syndrome | 1 | 2011 | 2337 | 0.150 |
Why?
|
Necrosis | 3 | 2013 | 1643 | 0.150 |
Why?
|
Melanoma | 1 | 2015 | 5510 | 0.150 |
Why?
|
Drug Resistance, Multiple | 1 | 2018 | 252 | 0.150 |
Why?
|
Isoenzymes | 1 | 2002 | 1726 | 0.140 |
Why?
|
ROC Curve | 2 | 2017 | 3527 | 0.140 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 1999 | 599 | 0.140 |
Why?
|
Random Allocation | 4 | 2016 | 2429 | 0.140 |
Why?
|
Sensitivity and Specificity | 7 | 2017 | 14722 | 0.140 |
Why?
|
Amnesia | 1 | 1998 | 248 | 0.140 |
Why?
|
Skin Neoplasms | 1 | 2015 | 5686 | 0.140 |
Why?
|
Pregnenediones | 1 | 2015 | 29 | 0.140 |
Why?
|
Nitric Oxide Synthase Type III | 2 | 2009 | 689 | 0.130 |
Why?
|
Splanchnic Circulation | 1 | 2016 | 110 | 0.130 |
Why?
|
Behavior, Animal | 2 | 2014 | 1881 | 0.130 |
Why?
|
Area Under Curve | 2 | 2017 | 1654 | 0.130 |
Why?
|
Diving | 2 | 2011 | 39 | 0.130 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2021 | 924 | 0.130 |
Why?
|
Algorithms | 4 | 2009 | 13881 | 0.130 |
Why?
|
Early Diagnosis | 2 | 2011 | 1184 | 0.130 |
Why?
|
Citrates | 1 | 2015 | 131 | 0.120 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2019 | 3327 | 0.120 |
Why?
|
Acute Disease | 7 | 2010 | 7149 | 0.120 |
Why?
|
Blood Transfusion, Autologous | 1 | 2015 | 134 | 0.120 |
Why?
|
Echocardiography, Three-Dimensional | 1 | 2020 | 591 | 0.120 |
Why?
|
Erythrocyte Indices | 1 | 2015 | 146 | 0.120 |
Why?
|
Awareness | 1 | 1998 | 640 | 0.120 |
Why?
|
Hearing Loss, Noise-Induced | 1 | 2015 | 145 | 0.120 |
Why?
|
Time Factors | 17 | 2019 | 40075 | 0.120 |
Why?
|
Immunosuppressive Agents | 1 | 2007 | 4149 | 0.120 |
Why?
|
Wound Infection | 1 | 2016 | 242 | 0.120 |
Why?
|
Evidence-Based Medicine | 1 | 2005 | 3610 | 0.110 |
Why?
|
Locus Coeruleus | 1 | 2014 | 176 | 0.110 |
Why?
|
Prospective Studies | 15 | 2024 | 53288 | 0.110 |
Why?
|
Lung | 3 | 2011 | 9856 | 0.110 |
Why?
|
Humidity | 1 | 2014 | 197 | 0.110 |
Why?
|
Pregnancy | 4 | 2022 | 29144 | 0.110 |
Why?
|
Electrodes, Implanted | 2 | 2015 | 824 | 0.110 |
Why?
|
Vagus Nerve | 1 | 2015 | 438 | 0.110 |
Why?
|
Cyanosis | 1 | 2013 | 83 | 0.110 |
Why?
|
Sensory Thresholds | 1 | 2014 | 391 | 0.110 |
Why?
|
Single-Blind Method | 3 | 2010 | 1590 | 0.110 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2014 | 214 | 0.110 |
Why?
|
Nerve Fibers, Myelinated | 2 | 2009 | 957 | 0.110 |
Why?
|
Databases, Nucleic Acid | 1 | 2013 | 211 | 0.110 |
Why?
|
Heart Diseases | 2 | 2003 | 2788 | 0.110 |
Why?
|
Anticoagulants | 3 | 2023 | 4599 | 0.110 |
Why?
|
Ulcer | 1 | 2013 | 209 | 0.100 |
Why?
|
Cohort Studies | 8 | 2022 | 40561 | 0.100 |
Why?
|
Psychomotor Disorders | 1 | 2012 | 152 | 0.100 |
Why?
|
Decompression Sickness | 1 | 2011 | 12 | 0.100 |
Why?
|
Decompression | 1 | 2011 | 43 | 0.100 |
Why?
|
Heparin | 1 | 2019 | 1637 | 0.100 |
Why?
|
Foot Injuries | 1 | 2013 | 148 | 0.100 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2013 | 232 | 0.100 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2016 | 567 | 0.100 |
Why?
|
Hypertension | 5 | 2021 | 8480 | 0.100 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2013 | 8949 | 0.100 |
Why?
|
Fatigue Syndrome, Chronic | 1 | 2013 | 214 | 0.100 |
Why?
|
Telangiectasis | 1 | 2011 | 76 | 0.100 |
Why?
|
Secondary Prevention | 2 | 2024 | 1530 | 0.100 |
Why?
|
Iatrogenic Disease | 1 | 2014 | 547 | 0.100 |
Why?
|
Antihypertensive Agents | 1 | 2021 | 2046 | 0.100 |
Why?
|
Internet | 3 | 2013 | 3064 | 0.100 |
Why?
|
Antiparkinson Agents | 1 | 2012 | 184 | 0.100 |
Why?
|
Kidney | 1 | 2007 | 7186 | 0.100 |
Why?
|
Ischemia | 2 | 2020 | 1907 | 0.100 |
Why?
|
Neurologic Examination | 2 | 2008 | 930 | 0.100 |
Why?
|
Bacteriological Techniques | 1 | 2012 | 277 | 0.100 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2013 | 341 | 0.090 |
Why?
|
Cryopreservation | 1 | 2015 | 670 | 0.090 |
Why?
|
Femur Head | 1 | 2012 | 301 | 0.090 |
Why?
|
Brain Stem Infarctions | 2 | 2001 | 32 | 0.090 |
Why?
|
Confusion | 1 | 2012 | 275 | 0.090 |
Why?
|
Comorbidity | 4 | 2009 | 10388 | 0.090 |
Why?
|
Tissue Plasminogen Activator | 1 | 2016 | 1261 | 0.090 |
Why?
|
Sex Factors | 3 | 2015 | 10397 | 0.090 |
Why?
|
Ablation Techniques | 1 | 2012 | 249 | 0.090 |
Why?
|
Diabetic Neuropathies | 1 | 2013 | 400 | 0.090 |
Why?
|
Intracranial Arterial Diseases | 1 | 2009 | 22 | 0.090 |
Why?
|
Teratogens | 1 | 2010 | 112 | 0.090 |
Why?
|
Diagnosis, Differential | 7 | 2011 | 12959 | 0.090 |
Why?
|
Platelet Function Tests | 1 | 2011 | 270 | 0.090 |
Why?
|
Aphasia | 1 | 2010 | 179 | 0.090 |
Why?
|
Electroencephalography | 4 | 2005 | 6150 | 0.090 |
Why?
|
Incidence | 8 | 2018 | 20947 | 0.090 |
Why?
|
Brain Diseases | 1 | 1998 | 1563 | 0.080 |
Why?
|
Electrocardiography | 3 | 2011 | 6442 | 0.080 |
Why?
|
Parkinsonian Disorders | 1 | 2012 | 275 | 0.080 |
Why?
|
Embolism | 1 | 2012 | 408 | 0.080 |
Why?
|
Paranasal Sinuses | 1 | 2011 | 250 | 0.080 |
Why?
|
Vomiting | 1 | 2012 | 636 | 0.080 |
Why?
|
Otoscopy | 1 | 2008 | 36 | 0.080 |
Why?
|
Thrombosis | 1 | 2003 | 2968 | 0.080 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2011 | 371 | 0.080 |
Why?
|
Gene Regulatory Networks | 2 | 2018 | 1708 | 0.080 |
Why?
|
Nasal Mucosa | 1 | 2011 | 373 | 0.080 |
Why?
|
Skin | 2 | 2012 | 4364 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2024 | 9239 | 0.080 |
Why?
|
Ozone | 1 | 2011 | 469 | 0.080 |
Why?
|
Firearms | 1 | 2015 | 598 | 0.080 |
Why?
|
Neuroradiography | 1 | 2008 | 70 | 0.080 |
Why?
|
Tandem Repeat Sequences | 1 | 2009 | 185 | 0.080 |
Why?
|
Echocardiography, Transesophageal | 2 | 2005 | 1133 | 0.080 |
Why?
|
Pressure | 2 | 2016 | 1203 | 0.080 |
Why?
|
Attention | 1 | 1998 | 2400 | 0.080 |
Why?
|
Data Collection | 2 | 2014 | 3341 | 0.080 |
Why?
|
Remission Induction | 1 | 2013 | 2386 | 0.080 |
Why?
|
Temperature | 1 | 2014 | 2206 | 0.080 |
Why?
|
Colon | 1 | 2016 | 1772 | 0.080 |
Why?
|
Eye Abnormalities | 1 | 2010 | 246 | 0.080 |
Why?
|
Iodine | 1 | 2009 | 286 | 0.080 |
Why?
|
Hot Temperature | 1 | 2013 | 1354 | 0.080 |
Why?
|
Cerebellum | 1 | 2014 | 1488 | 0.070 |
Why?
|
Specimen Handling | 1 | 2012 | 694 | 0.070 |
Why?
|
International Cooperation | 2 | 2011 | 1420 | 0.070 |
Why?
|
Proportional Hazards Models | 2 | 2013 | 12354 | 0.070 |
Why?
|
Vasodilation | 2 | 2009 | 944 | 0.070 |
Why?
|
Brain Mapping | 3 | 2012 | 6669 | 0.070 |
Why?
|
Intracranial Embolism | 1 | 2008 | 202 | 0.070 |
Why?
|
Liver | 1 | 2022 | 7474 | 0.070 |
Why?
|
Anatomy, Artistic | 1 | 2006 | 52 | 0.070 |
Why?
|
Pravastatin | 1 | 2008 | 395 | 0.070 |
Why?
|
Brachial Artery | 1 | 2008 | 369 | 0.070 |
Why?
|
Medical Illustration | 1 | 2006 | 133 | 0.070 |
Why?
|
Malondialdehyde | 3 | 2012 | 105 | 0.070 |
Why?
|
Corpus Striatum | 1 | 2012 | 1221 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 1 | 2015 | 1790 | 0.070 |
Why?
|
Military Personnel | 2 | 2005 | 1133 | 0.070 |
Why?
|
Emergencies | 1 | 2012 | 1170 | 0.070 |
Why?
|
Sex Distribution | 1 | 2011 | 2297 | 0.070 |
Why?
|
Follow-Up Studies | 5 | 2016 | 39050 | 0.070 |
Why?
|
Drug Administration Schedule | 2 | 2019 | 4933 | 0.060 |
Why?
|
Organ Transplantation | 1 | 2015 | 1139 | 0.060 |
Why?
|
Mastoid | 1 | 2005 | 92 | 0.060 |
Why?
|
Genetic Association Studies | 1 | 2014 | 2703 | 0.060 |
Why?
|
Platelet Aggregation | 1 | 2008 | 798 | 0.060 |
Why?
|
Analysis of Variance | 2 | 2011 | 6365 | 0.060 |
Why?
|
Air | 1 | 2005 | 182 | 0.060 |
Why?
|
Age Distribution | 1 | 2011 | 2902 | 0.060 |
Why?
|
Thromboangiitis Obliterans | 1 | 2004 | 10 | 0.060 |
Why?
|
Free Radical Scavengers | 1 | 2005 | 216 | 0.060 |
Why?
|
Cadaver | 1 | 2008 | 1337 | 0.060 |
Why?
|
Kidney Function Tests | 1 | 2007 | 684 | 0.060 |
Why?
|
Vasoconstrictor Agents | 1 | 2008 | 642 | 0.060 |
Why?
|
High Pressure Neurological Syndrome | 1 | 2004 | 3 | 0.060 |
Why?
|
Europe | 3 | 2019 | 3339 | 0.060 |
Why?
|
Byzantium | 1 | 2003 | 1 | 0.060 |
Why?
|
Mood Disorders | 1 | 2011 | 1106 | 0.060 |
Why?
|
Infarction | 2 | 2022 | 244 | 0.060 |
Why?
|
Lymphocytes | 1 | 2012 | 2617 | 0.060 |
Why?
|
History, Medieval | 1 | 2003 | 63 | 0.060 |
Why?
|
Genome-Wide Association Study | 4 | 2019 | 12261 | 0.060 |
Why?
|
Administration, Inhalation | 1 | 2007 | 1105 | 0.060 |
Why?
|
Chlorates | 1 | 2003 | 13 | 0.060 |
Why?
|
Ultrasonography, Doppler, Transcranial | 1 | 2005 | 292 | 0.060 |
Why?
|
Sleep | 1 | 2020 | 4623 | 0.060 |
Why?
|
Spectrum Analysis | 1 | 2005 | 454 | 0.060 |
Why?
|
Embolism, Air | 1 | 2004 | 111 | 0.060 |
Why?
|
Laparoscopy | 1 | 2016 | 2151 | 0.060 |
Why?
|
Neuronal Plasticity | 1 | 2012 | 1422 | 0.060 |
Why?
|
Austria | 1 | 2003 | 203 | 0.060 |
Why?
|
Apoptosis | 1 | 2020 | 9727 | 0.060 |
Why?
|
Genotype | 2 | 2019 | 12951 | 0.060 |
Why?
|
Medical Records Systems, Computerized | 1 | 2010 | 1205 | 0.060 |
Why?
|
Migraine Disorders | 1 | 2015 | 1620 | 0.060 |
Why?
|
Microcirculation | 1 | 2008 | 1286 | 0.060 |
Why?
|
United States | 7 | 2016 | 69872 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6538 | 0.050 |
Why?
|
Case-Control Studies | 5 | 2019 | 21746 | 0.050 |
Why?
|
Wakefulness | 1 | 2010 | 1245 | 0.050 |
Why?
|
Suicide, Attempted | 1 | 2011 | 1221 | 0.050 |
Why?
|
Complex Regional Pain Syndromes | 1 | 2004 | 124 | 0.050 |
Why?
|
Glucose | 1 | 2015 | 4397 | 0.050 |
Why?
|
Drug Synergism | 1 | 2007 | 1792 | 0.050 |
Why?
|
Fetus | 1 | 2010 | 1880 | 0.050 |
Why?
|
DNA Damage | 1 | 2012 | 2432 | 0.050 |
Why?
|
Reactive Oxygen Species | 2 | 2007 | 2077 | 0.050 |
Why?
|
Thalamic Diseases | 1 | 2001 | 16 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2014 | 2408 | 0.050 |
Why?
|
Atrial Appendage | 1 | 2005 | 283 | 0.050 |
Why?
|
Myoglobin | 1 | 2002 | 160 | 0.050 |
Why?
|
Medical Errors | 1 | 2010 | 1297 | 0.050 |
Why?
|
Nurses | 1 | 2011 | 2461 | 0.050 |
Why?
|
Oxygen Consumption | 1 | 2008 | 1869 | 0.050 |
Why?
|
Retina | 1 | 2012 | 2616 | 0.050 |
Why?
|
Creatine Kinase, MB Form | 1 | 2002 | 214 | 0.050 |
Why?
|
Arteries | 1 | 2006 | 1119 | 0.050 |
Why?
|
Cesarean Section | 1 | 2010 | 1365 | 0.050 |
Why?
|
History, 19th Century | 1 | 2003 | 720 | 0.050 |
Why?
|
Syndrome | 2 | 2005 | 3251 | 0.050 |
Why?
|
Patient Admission | 1 | 2008 | 1380 | 0.050 |
Why?
|
Registries | 1 | 2016 | 8089 | 0.050 |
Why?
|
Dominance, Cerebral | 2 | 2001 | 635 | 0.050 |
Why?
|
Diffusion Tensor Imaging | 1 | 2011 | 2305 | 0.050 |
Why?
|
Parietal Lobe | 1 | 2006 | 838 | 0.050 |
Why?
|
Echo-Planar Imaging | 1 | 2005 | 659 | 0.050 |
Why?
|
Survival Analysis | 1 | 2013 | 10252 | 0.050 |
Why?
|
Immunohistochemistry | 2 | 2015 | 11366 | 0.050 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2007 | 770 | 0.050 |
Why?
|
Diabetes Mellitus | 3 | 2010 | 5751 | 0.050 |
Why?
|
Sex Characteristics | 1 | 2011 | 2585 | 0.050 |
Why?
|
Blood Glucose | 1 | 2015 | 6256 | 0.050 |
Why?
|
Myocardial Ischemia | 1 | 2011 | 2148 | 0.050 |
Why?
|
Medication Therapy Management | 1 | 2021 | 127 | 0.040 |
Why?
|
Melatonin | 1 | 2005 | 721 | 0.040 |
Why?
|
Fibromyalgia | 1 | 2004 | 388 | 0.040 |
Why?
|
Graft Survival | 2 | 2015 | 3737 | 0.040 |
Why?
|
Homocysteine | 1 | 2003 | 647 | 0.040 |
Why?
|
Ataxia | 1 | 2001 | 304 | 0.040 |
Why?
|
Age Factors | 3 | 2015 | 18370 | 0.040 |
Why?
|
Nitric Oxide | 1 | 2008 | 2132 | 0.040 |
Why?
|
Prevalence | 3 | 2014 | 15226 | 0.040 |
Why?
|
Genetic Loci | 2 | 2019 | 2575 | 0.040 |
Why?
|
Recovery of Function | 3 | 2015 | 2925 | 0.040 |
Why?
|
Staphylococcus aureus | 2 | 2018 | 1451 | 0.040 |
Why?
|
Parents | 1 | 2012 | 3407 | 0.040 |
Why?
|
Disease Models, Animal | 3 | 2015 | 18029 | 0.040 |
Why?
|
Inpatients | 1 | 2010 | 2518 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2018 | 15519 | 0.040 |
Why?
|
DNA | 1 | 2012 | 7301 | 0.040 |
Why?
|
Disaster Planning | 1 | 2004 | 549 | 0.040 |
Why?
|
Alzheimer Disease | 1 | 2018 | 8037 | 0.040 |
Why?
|
Sensation Disorders | 1 | 1998 | 155 | 0.040 |
Why?
|
Blood Platelets | 1 | 2008 | 2508 | 0.040 |
Why?
|
Linear Models | 1 | 2008 | 5952 | 0.040 |
Why?
|
Young Adult | 5 | 2015 | 56430 | 0.040 |
Why?
|
Adolescent | 10 | 2013 | 85781 | 0.040 |
Why?
|
Rabbits | 1 | 2003 | 4894 | 0.040 |
Why?
|
Blood Pressure Determination | 1 | 2021 | 634 | 0.040 |
Why?
|
Emergency Medical Services | 1 | 2008 | 1917 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2018 | 279 | 0.040 |
Why?
|
Molecular Weight | 1 | 1999 | 2255 | 0.040 |
Why?
|
Hydroxyproline | 1 | 2016 | 116 | 0.030 |
Why?
|
Hospitals | 1 | 2010 | 3952 | 0.030 |
Why?
|
Klebsiella pneumoniae | 1 | 2018 | 251 | 0.030 |
Why?
|
Preventive Health Services | 1 | 2021 | 575 | 0.030 |
Why?
|
Hearing Loss, Bilateral | 1 | 2015 | 54 | 0.030 |
Why?
|
Hearing Loss, Unilateral | 1 | 2015 | 26 | 0.030 |
Why?
|
Hospitals, University | 2 | 2010 | 571 | 0.030 |
Why?
|
Software | 1 | 2009 | 4443 | 0.030 |
Why?
|
Tomography, Emission-Computed | 1 | 1998 | 1144 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2021 | 921 | 0.030 |
Why?
|
Epilepsy, Absence | 1 | 1995 | 48 | 0.030 |
Why?
|
Computer Simulation | 1 | 2008 | 6196 | 0.030 |
Why?
|
Tensile Strength | 1 | 2016 | 335 | 0.030 |
Why?
|
Cardiovascular Diseases | 3 | 2010 | 15165 | 0.030 |
Why?
|
Escherichia coli | 2 | 2018 | 4217 | 0.030 |
Why?
|
Atrophy | 1 | 2018 | 1583 | 0.030 |
Why?
|
Kinetics | 1 | 2002 | 6473 | 0.030 |
Why?
|
Antioxidants | 2 | 2012 | 1663 | 0.030 |
Why?
|
Corpus Callosum | 1 | 1998 | 737 | 0.030 |
Why?
|
Neuroglia | 1 | 1999 | 927 | 0.030 |
Why?
|
Logistic Models | 1 | 2008 | 13408 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2016 | 15295 | 0.030 |
Why?
|
Blood Flow Velocity | 2 | 2008 | 1423 | 0.030 |
Why?
|
Models, Statistical | 1 | 2008 | 5102 | 0.030 |
Why?
|
Social Class | 1 | 2022 | 1999 | 0.030 |
Why?
|
Linkage Disequilibrium | 1 | 2018 | 1997 | 0.030 |
Why?
|
Purkinje Cells | 1 | 2014 | 224 | 0.030 |
Why?
|
Comet Assay | 1 | 2012 | 71 | 0.030 |
Why?
|
DNA Breaks, Single-Stranded | 1 | 2012 | 23 | 0.030 |
Why?
|
Odds Ratio | 3 | 2014 | 9849 | 0.030 |
Why?
|
Radiography | 3 | 2013 | 7023 | 0.030 |
Why?
|
Anastomosis, Surgical | 1 | 2016 | 987 | 0.030 |
Why?
|
Oxidopamine | 1 | 2012 | 169 | 0.030 |
Why?
|
Atmosphere | 1 | 2011 | 33 | 0.030 |
Why?
|
Escherichia coli Infections | 1 | 2016 | 532 | 0.030 |
Why?
|
Seizures | 1 | 2004 | 2859 | 0.030 |
Why?
|
Echocardiography | 2 | 2005 | 5102 | 0.030 |
Why?
|
Protein Carbonylation | 1 | 2011 | 29 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2019 | 2309 | 0.020 |
Why?
|
Reference Standards | 1 | 2014 | 1025 | 0.020 |
Why?
|
Autopsy | 1 | 2014 | 1020 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2018 | 1783 | 0.020 |
Why?
|
Infusions, Intra-Arterial | 1 | 2011 | 234 | 0.020 |
Why?
|
Quality Control | 1 | 2013 | 841 | 0.020 |
Why?
|
Pseudomonas aeruginosa | 1 | 2018 | 1219 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2015 | 1641 | 0.020 |
Why?
|
Housing | 1 | 2014 | 664 | 0.020 |
Why?
|
Medical Audit | 1 | 2011 | 467 | 0.020 |
Why?
|
Hypertrophy | 1 | 2011 | 569 | 0.020 |
Why?
|
Child, Preschool | 1 | 2012 | 41006 | 0.020 |
Why?
|
Hemodynamics | 1 | 2020 | 4199 | 0.020 |
Why?
|
Dendrites | 1 | 2012 | 485 | 0.020 |
Why?
|
Heme Oxygenase-1 | 1 | 2011 | 381 | 0.020 |
Why?
|
Brain Damage, Chronic | 1 | 2010 | 265 | 0.020 |
Why?
|
Cell Survival | 1 | 1999 | 5882 | 0.020 |
Why?
|
Reperfusion | 1 | 2010 | 284 | 0.020 |
Why?
|
Myocardial Infarction | 2 | 2010 | 11727 | 0.020 |
Why?
|
Bleeding Time | 1 | 2008 | 89 | 0.020 |
Why?
|
Ornithine | 1 | 2008 | 78 | 0.020 |
Why?
|
Anisotropy | 1 | 2012 | 1265 | 0.020 |
Why?
|
Perfusion Imaging | 1 | 2010 | 195 | 0.020 |
Why?
|
Review Literature as Topic | 1 | 2010 | 336 | 0.020 |
Why?
|
Neovascularization, Physiologic | 1 | 2015 | 1351 | 0.020 |
Why?
|
Cell Division | 1 | 2016 | 4568 | 0.020 |
Why?
|
Cell Count | 1 | 2012 | 1856 | 0.020 |
Why?
|
Nitroglycerin | 1 | 2009 | 325 | 0.020 |
Why?
|
Anus Diseases | 1 | 2008 | 59 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2012 | 1100 | 0.020 |
Why?
|
Laser-Doppler Flowmetry | 1 | 2008 | 242 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 1 | 2013 | 1877 | 0.020 |
Why?
|
Models, Genetic | 1 | 2018 | 3494 | 0.020 |
Why?
|
Vasomotor System | 1 | 2008 | 209 | 0.020 |
Why?
|
Phenylephrine | 1 | 2008 | 301 | 0.020 |
Why?
|
Arthritis | 1 | 2013 | 659 | 0.020 |
Why?
|
Oxyhemoglobins | 1 | 2008 | 216 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2015 | 4776 | 0.020 |
Why?
|
Stress, Physiological | 1 | 2014 | 1403 | 0.020 |
Why?
|
Blood Circulation Time | 1 | 2006 | 11 | 0.020 |
Why?
|
Staphylococcal Infections | 1 | 2016 | 1400 | 0.020 |
Why?
|
Troponin I | 1 | 2011 | 619 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2012 | 1375 | 0.020 |
Why?
|
Forearm | 1 | 2009 | 409 | 0.020 |
Why?
|
Ear, Middle | 1 | 2008 | 334 | 0.020 |
Why?
|
Introns | 1 | 2009 | 991 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2011 | 2274 | 0.020 |
Why?
|
Amyloid beta-Peptides | 1 | 2018 | 3587 | 0.020 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2009 | 780 | 0.020 |
Why?
|
Computational Biology | 1 | 2018 | 3521 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2012 | 1312 | 0.020 |
Why?
|
American Heart Association | 1 | 2010 | 1056 | 0.020 |
Why?
|
Injections, Intraperitoneal | 1 | 2005 | 425 | 0.020 |
Why?
|
Acoustic Impedance Tests | 1 | 2005 | 109 | 0.020 |
Why?
|
Fibroblasts | 1 | 2016 | 4161 | 0.020 |
Why?
|
Hearing Disorders | 1 | 2005 | 124 | 0.020 |
Why?
|
Internationality | 1 | 2010 | 1003 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2018 | 3647 | 0.020 |
Why?
|
Submarine Medicine | 1 | 2004 | 4 | 0.020 |
Why?
|
Arginine | 1 | 2008 | 944 | 0.020 |
Why?
|
Tinnitus | 1 | 2007 | 195 | 0.020 |
Why?
|
Pain Measurement | 2 | 2004 | 3420 | 0.010 |
Why?
|
Abscess | 1 | 2008 | 607 | 0.010 |
Why?
|
Patient Readmission | 1 | 2018 | 3114 | 0.010 |
Why?
|
Patient Discharge | 1 | 2016 | 3313 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 3870 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8642 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2013 | 2278 | 0.010 |
Why?
|
Databases as Topic | 1 | 2004 | 475 | 0.010 |
Why?
|
Wrist | 1 | 2004 | 224 | 0.010 |
Why?
|
Graft Rejection | 1 | 2015 | 4397 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 2 | 2018 | 17446 | 0.010 |
Why?
|
Reperfusion Injury | 1 | 2009 | 1026 | 0.010 |
Why?
|
Haplotypes | 1 | 2009 | 2779 | 0.010 |
Why?
|
Gene Frequency | 1 | 2009 | 3588 | 0.010 |
Why?
|
Cell Differentiation | 1 | 1999 | 11483 | 0.010 |
Why?
|
Hemoglobins | 1 | 2007 | 1534 | 0.010 |
Why?
|
Nervous System Diseases | 1 | 2012 | 1622 | 0.010 |
Why?
|
Portal Vein | 1 | 2004 | 437 | 0.010 |
Why?
|
Unconsciousness | 1 | 2003 | 263 | 0.010 |
Why?
|
Vision, Ocular | 1 | 2004 | 464 | 0.010 |
Why?
|
Information Storage and Retrieval | 1 | 2006 | 824 | 0.010 |
Why?
|
Pain Threshold | 1 | 2004 | 584 | 0.010 |
Why?
|
Multiple Sclerosis | 1 | 1995 | 3079 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8388 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2006 | 2373 | 0.010 |
Why?
|
Double-Blind Method | 2 | 2004 | 12026 | 0.010 |
Why?
|
Biopsy | 1 | 2012 | 6756 | 0.010 |
Why?
|
Edema | 1 | 2004 | 789 | 0.010 |
Why?
|
Death, Sudden, Cardiac | 1 | 2008 | 1541 | 0.010 |
Why?
|
Femoral Artery | 1 | 2004 | 845 | 0.010 |
Why?
|
Placebos | 1 | 2004 | 1676 | 0.010 |
Why?
|
Child | 4 | 2012 | 77709 | 0.010 |
Why?
|
Length of Stay | 1 | 2013 | 6309 | 0.010 |
Why?
|
Light | 1 | 2005 | 1374 | 0.010 |
Why?
|
Pilot Projects | 1 | 2012 | 8324 | 0.010 |
Why?
|
Pain | 2 | 2004 | 4986 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7279 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2009 | 4328 | 0.010 |
Why?
|
Arrhythmias, Cardiac | 1 | 2008 | 2268 | 0.010 |
Why?
|
Embolization, Therapeutic | 1 | 2008 | 1392 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2008 | 3798 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2009 | 5867 | 0.010 |
Why?
|
Emergency Service, Hospital | 2 | 2010 | 7659 | 0.010 |
Why?
|
Mice | 2 | 2018 | 81183 | 0.010 |
Why?
|
Homeostasis | 1 | 2008 | 3340 | 0.010 |
Why?
|
Massachusetts | 1 | 2009 | 8663 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2008 | 2899 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2009 | 4456 | 0.010 |
Why?
|
Reference Values | 1 | 2004 | 4982 | 0.010 |
Why?
|
Image Enhancement | 1 | 2006 | 2921 | 0.010 |
Why?
|
Thalamus | 1 | 2001 | 1023 | 0.010 |
Why?
|
Epilepsy, Tonic-Clonic | 1 | 1995 | 49 | 0.010 |
Why?
|
Crohn Disease | 1 | 2008 | 2303 | 0.010 |
Why?
|
Intestines | 1 | 2004 | 1924 | 0.010 |
Why?
|
Ultrasonography | 1 | 2008 | 5985 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2006 | 4042 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2008 | 13033 | 0.010 |
Why?
|
Quality of Life | 1 | 2013 | 12804 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2000 | 12245 | 0.000 |
Why?
|
Infant | 1 | 2001 | 35136 | 0.000 |
Why?
|